依诺昔酮(Enoximone)为新型的磷酸二酯酶Ⅲ抑制剂,系咪唑酮类衍生物,是一种非甙非儿茶酚胺类强心药,兼有正性肌力和扩张血管作用,静注和口服均有效。能明显改善充血性心力衰竭(CHF)患者的血流动力学,不良反应较少且易耐受,是一种颇有前途的抗心衰药物。 [化学名称]1,3—二氢—4—甲基—5—[4—甲硫基苯甲酰]—2H—咪唑—2—酮。 Enoximone is a new type of phosphodiesterase III inhibitor, which is a kind of non-glycosidic non-catecholamine cardiomics, which is a kind of midazolam derivative. It has both positive inotropic and dilating effects, And oral are effective. Can significantly improve hemodynamics in patients with congestive heart failure (CHF), less adverse reactions and easy to tolerate, is a promising anti-heart failure drugs. [Chemical Name] 1,3-Dihydro-4-methyl-5- [4-methylthiobenzoyl] -2H-imidazol-2-one.